. 2020 Apr 28;10:7166. doi: 10.1038/s41598-020-64097-y

Table 4.

Cardiac parameters calculated from CMR exams performed through the study. Data presented as mean±standard deviation.

Group	CON	MSPs	IGF-1 MSPs
LVEF (%) pre-injection	26 ± 9^a	31 ± 11	33 ± 10^a
LVEF (%) 10 weeks	36 ± 8^a,*	37 ± 20**	51 ± 8^a,^,*
EDVi (ml/m²) pre-injection	68 ± 16	74 ± 14	77 ± 12^a
EDVi (ml/m²) 10 weeks	86 ± 22	81 ± 17	89 ± 14^a
ESVi (ml/m²) pre-injection	51 ± 22	50 ± 8	52 ± 14
ESVi (ml/m²) 10 weeks	56 ± 20	50 ± 13	44 ± 12
IS (%) pre-injection	20 ± 8^a	20 ± 5^a	18 ± 7^a
IS (%) 10 weeks	9 ± 4^a	10 ± 3^a	11 ± 4^a

Intragroup and Intergroup comparisons at each time point are denoted by ^a p < 0.05 and *p < 0.05, respectively.